About

Lantern Kestrel publishes Clear Almanac 62 as an independent resource on ibogaine, evidence, risks, and policy. Our work is focused on clear, cautious summaries and transparent sourcing so people can separate early findings from established care.

We are not a clinic or a provider; the materials here are informational and do not constitute medical or legal advice.

Close-up detail view related to ibogaine treatment, textured organic surface suggestive of a clinical photograph

Our editorial approach

Clear Almanac 62 was created to make careful information about ibogaine available without advocacy or hype. We synthesize public registries, peer-reviewed literature, and official guidance, and we clearly flag the difference between preliminary reports and established clinical practice.

To support transparency, our process emphasizes traceable sourcing and neutral framing. For example, when we cite a regulatory concept we reference the issuing body or a canonical overview such as a relevant Wikipedia entry on scientific review processes (peer review) or an institutional guideline on evidence evaluation from a university health research office (the NIH).

Readers interested in the scope of our services and summaries can find contextual information on our services page, which describes the types of editorial products and trackers we maintain.

What we cover

We publish concise explainers, research trackers, safety summaries, and policy updates related to ibogaine and its broader context. Our content is organized by topic area (evidence, safety, policy) and by resource type (briefs, trackers, annotated bibliographies) so readers can quickly find audits, primary citations, and plain-language summaries.

We also link readers to relevant external resources when appropriate — for instance, clinical registries or informational pages hosted by recognized authorities; such links are used solely to point to primary sources rather than to endorse any provider. For practical information about treatment facilities, readers sometimes consult directories such as ibogaine treatment centers in Canada, while keeping in mind our guidance on risks and evidence.

How information is sourced and vetted

We rely on public registries, peer-reviewed literature, official guidance, and primary reports. When summarizing a study or registry entry we describe study design, sample size, and limitations — drawing on established frameworks for evidence appraisal such as those summarized by university research offices (Harvard University) or public health agencies (CDC).

All factual claims in our pieces include inline citations to the original source where possible. Corrections and updates are tracked transparently; when a significant new study emerges we update the related tracker and note the change.

Who this is for

This resource is designed for people seeking clear, cautious information about ibogaine, substance-use treatment options, and emerging research — including family members, clinicians looking for summaries, and policy researchers. If you are searching for clinical care, the pages under our Services section explain our editorial tools and trackers; they do not serve as treatment referrals.

Editorial principles

  • Independence — we do not accept payment that biases coverage.
  • Evidence before claims — prioritize rigorous designs and transparent limits.
  • Risk clarity — describe harms and uncertainty plainly and early.
  • Plain language — make technical findings accessible without oversimplifying.
  • Respect for uncertainty — avoid definitive claims when the evidence is mixed.

Independent by design

Lantern Kestrel is an independent information resource and is not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. For those seeking treatment providers directly, consider verified registries and official guidance while weighing risks carefully; our services overview describes how we track and present that information.

Contact

FAQ — sourcing & corrections

How do you verify a study? We look for peer review, sample transparency, and conflict-of-interest disclosures; when in doubt we flag uncertainty and link to the original source such as a PubMed entry or institutional repository (PubMed).

How do I suggest a correction? Use the Contact page to submit evidence and citations; we review and, when appropriate, correct with an editor's note.

Does Clear Almanac 62 provide referrals? No — we do not act as a referral service. Readers seeking treatment should consult licensed healthcare providers and official registries maintained by public health authorities (WHO).